Literature DB >> 6179989

The role of three distinct Ia-like antigen molecules in human T cell proliferative responses: effect of monoclonal anti-Ia-like antibodies.

Y Koide, F Awashima, T O Yoshida, T Takenouchi, A Wakisaka, J Moriuchi, M Aizawa.   

Abstract

Murine monoclonal antibodies (MoAb) to three distinct Ia-like molecules were studied for their inhibitory effects on antigen- and alloantigen-induced T cell proliferations. The MoAb were classified into three groups according to the molecules they recognized. Both the group I MoAb reacting with DR molecules and the group III MoAb were capable of inhibiting T cell proliferative responses to PPD- and HSV-Ag-pulsed APC, autologous B-LCL, and alloantigens. On th other hand, the group II MoAb, which reacted with a determinant on the molecule carrying MB1 determinants, was only capable of inhibiting T cell responses to alloantigens. These results suggest that the structure of the molecules correlates with the functional repertoire of the human Ia-like antigens.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6179989

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  9 in total

1.  HLA-DQ-controlled T cell response to soluble egg antigen of Schistosoma japonicum in humans.

Authors:  N Ohta; T Edahiro; A Ishii; M Yasukawa; Y Hosaka
Journal:  Clin Exp Immunol       Date:  1990-03       Impact factor: 4.330

2.  Inhibition of autologous mixed lymphocyte reaction by monoclonal antibodies specific for the beta chain of HLA-DR antigens.

Authors:  M Kasahara; H Ikeda; K Ogasawara; N Ishikawa; T Okuyama; Y Fukasawa; H Kojima; H Kunikane; S Hawkin; T Ohhashi
Journal:  Immunology       Date:  1984-09       Impact factor: 7.397

3.  Evidence for polymorphism of MB3 antigens among three HLA-D clusters associated with HLA-DR4.

Authors:  H Ikeda; M Kasahara; K Ogasawara; T Takenouchi; T Okuyama; N Ishikawa; A Wakisaka; Y Kikuchi; M Aizawa
Journal:  Immunogenetics       Date:  1984       Impact factor: 2.846

4.  Serologic dissection of HLA-D specificities by the use of monoclonal antibodies. II. Distinction between HLA-Dw2 and HLA-Dw12.

Authors:  M Kasahara; T Takenouchi; H Ikeda; K Ogasawara; T Okuyama; N Ishikawa; A Wakisaka; Y Kikuchi; M Aizawa
Journal:  Immunogenetics       Date:  1983       Impact factor: 2.846

5.  Serologic dissection of HLA-D specificities by the use of monoclonal antibodies.

Authors:  M Kasahara; T Takenouchi; K Ogasawara; H Ikeda; T Okuyama; N Ishikawa; J Moriuchi; A Wakisaka; Y Kikuchi; M Aizawa; T Kaneko; N Kashiwagi; Y Nishimura; T Sasazuki
Journal:  Immunogenetics       Date:  1983       Impact factor: 2.846

6.  Multiple sclerosis: I. Monocyte stimulatory defect in mixed lymphocyte reaction associated with clinical disease activity.

Authors:  C N Baxevanis; G J Reclos; C Sfagos; E Doufexis; C Papageorgiou; M Papamichail
Journal:  Clin Exp Immunol       Date:  1987-02       Impact factor: 4.330

7.  Antigen-specific HLA-restricted human T-cell lines. II. A GAT-specific T-cell line restricted by a determinant carried by an HLA-DQ molecule.

Authors:  E J Ball; P Stastny
Journal:  Immunogenetics       Date:  1984       Impact factor: 2.846

8.  Allele specificity of structural requirement for peptides bound to HLA-DRB1*0405 and -DRB1*0406 complexes: implication for the HLA-associated susceptibility to methimazole-induced insulin autoimmune syndrome.

Authors:  S Matsushita; K Takahashi; M Motoki; K Komoriya; S Ikagawa; Y Nishimura
Journal:  J Exp Med       Date:  1994-09-01       Impact factor: 14.307

9.  HLA-DR antigen expression in colorectal carcinomas: influence of expression by IFN-gamma in situ and its association with tumour progression.

Authors:  K Matsushita; T Takenouchi; S Kobayashi; H Hayashi; K Okuyama; T Ochiai; A Mikata; K Isono
Journal:  Br J Cancer       Date:  1996-03       Impact factor: 7.640

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.